-
Genome_wide_association_study_of_vaccine_responses_in_infants_living_in_the_Developing_World__VaccGene___Phase_II_African_Cohorts
Study
EGAS00001000918
-
Prediction and quantification of splice events from RNA-seq data
Study
EGAS00001001026
-
Post_Mortem_Tissue_COVID19_RNA
Study
EGAS00001004442
-
Targeting FGFR1 for treatment of soft-tissue sarcoma (H021)
Study
EGAS00001001844
-
Exome_Sequencing_of_Poor_Prognosis_Acute_Myeloid_Leukaemia
Study
EGAS00001000146
-
Glioblastoma_CRISPR_Screen
Study
EGAS00001001519
-
Papuan_Genotyping
Study
EGAS00001001587
-
Spatial and Temporal Homogeneity of Driver Mutations in Diffuse Intrinsic Pointine Glioma
Study
EGAS00001001654
-
Molecular sub-classification of hormone receptor-positive breast cancer
Study
EGAS00001004594
-
Indonesian Genome Diversity Project 2
Study
EGAS00001003654
-
PCa-LINES
Study
EGAS00001004613
-
Renal_habitat_WXS
Study
EGAS00001003703
-
Australia_and_New_Guinea_haplotype_phasing_
Study
EGAS00001001853
-
Identification of rare germline variants in familial multiple myeloma
Study
EGAS00001004734
-
Primary prostate Hi-C
Study
EGAS00001005014
-
Comprehensive Genomic and Transcriptomic Analysis of Rare Cancers for Guiding of Therapy (H021)
Study
EGAS00001004813
-
Indonesian Genome Diversity Project 2, genotyping data
Study
EGAS00001003670
-
The BC Cancer Agency's Personalized Onco-Genomics Project
Study
EGAS00001001159
-
The genomic landscape of germinal center derived B-cell lymphomas other than follicular, diffuse-large B-cell and Burkitt lymphom
Study
EGAS00001002422
-
Single-cell landscapes of primary glioblastomas and matched organoids and cell lines reveal variable retention of inter- and intra-tumor heterogeneity
Study
EGAS00001005227
-
Single cell RNAseq of PBMC from bladder cancer patients
Study
EGAS00001004008
-
H3Africa - An integrated approach to the identification of genetic determinants of susceptibility to trypanosomiasis
Study
EGAS00001002602
-
Defective Homologous Recombination DNA Repair as Therapeutic Target in Advanced-Stage Chordoma (HIPO_021)
Study
EGAS00001002720
-
The genomic and radiomic complexity of multifocal prostate cancer
Study
EGAS00001002767
-
Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma
Study
EGAS00001002812
-
Integrated clinical, whole genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
Study
EGAS00001001659
-
Post_Mortem_Tissue_COVID19_spatial
Study
EGAS00001004441
-
Spatial concordance of DNA methylation classification in diffuse glioma
Study
EGAS00001005434
-
Single cell RNAseq of PBMC from RCC patients
Study
EGAS00001004451
-
The Molecular Landscape of Asian Breast Cancers Reveals Clinically Relevant Population-Specific Differences
Study
EGAS00001004518
-
Whole genome, exome and transcriptome analysis to guide individualized cancer interpretation
Study
EGAS00001004013
-
Mapping the breast cancer metastatic cascade onto circulating tumour DNA using genetic and epigenetic clonal tracking
Study
EGAS00001004014
-
Tumor HTG EdgeSeq from metastatic castrate resistant prostate cancer
Study
EGAS00001004852
-
Small variants in mtDNA Canary Islands - WES Illumina (ITER)
Study
EGAS00001005678
-
Comprehensive pharmacogenomic characterization of gastric cancer
Study
EGAS00001004106
-
Small variants in mtDNA Canary Islands - WGS Illumina (ITER)
Study
EGAS00001005679
-
Persistence of circulating tumor DNA in breast cancer patients during neoadjuvant treatment is a significant predictor of poor tumor response
Study
EGAS00001005798
-
Application of Hi-C sequencing to detect structural variants in B-cell acute lymphoblastic leukemia
Study
EGAS00001005605
-
Genome-wide Ancestry and Demographic History of African-Descendant Maroon Communities from French Guiana and Surname.
Study
EGAS00001002535
-
An exome sequencing approach to defining the genetic risk factors for Achilles tendinopathy
Study
EGAS00001003234
-
Papua New Guinean Genome Diversity Project
Study
EGAS00001005393
-
CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase
Study
EGAS00001004455
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
Germline variants in patients with rare cancers and their implications for precision cancer medicine: experiences from the Multicenter MASTER Trial by the German Cancer Consortium (HIPO_021)
Study
EGAS00001005537
-
Small variants in mtDNA Canary Islands - WGS Oxford Nanopore Technologies (ITER)
Study
EGAS00001005677
-
Characterization of Cell Free Plasma Methyl-DNA From Xenografted Tumors to Guide the Selection of Diagnostic Markers for Early-Stage Cancers
Study
EGAS00001006175
-
Single_cell_characterization_of_T_cell_lymphoma_
Study
EGAS00001005750
-
Personalised therapy with MEK inhibition leads to a sustained complete response in an adolescent patient with a recurrent malignant peripheral nerve sheath tumor
Study
EGAS00001004899
-
Human genome-wide variations in the Massim region
Study
EGAS00001006010
-
Induced pluripotent stem cell lines (iPSC lines) produced from skin and blood cells.
Study
EGAS00001006262